Related Experiment Videos
Using the behavior change wheel to develop text messages intervention (MedText-PCI) to promote medication adherence
Fang Yong1, Han Zhihao2, Zhou Xi1
1Changsha Medical University, Changsha, China.
Frontiers in Digital Health
|May 25, 2026
Summary
Researchers developed MedText-PCI, a theory-informed text message intervention, to enhance medication adherence in patients following percutaneous coronary intervention (PCI). This intervention utilizes the Behaviour Change Wheel framework for improved patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Health Psychology
- Digital Health Interventions
Background:
- Medication non-adherence is a significant issue for patients post-percutaneous coronary intervention (PCI), impacting secondary prevention outcomes.
- Theory-based interventions are crucial for effectively addressing behavioral determinants of adherence.
- The Behaviour Change Wheel (BCW) framework offers a systematic approach to intervention design.
Purpose of the Study:
- To develop a theory-informed text message intervention (MedText-PCI) to improve medication adherence in patients after PCI.
- To apply the BCW framework and the COM-B model to guide intervention development.
- To create a reproducible and evidence-based intervention for post-PCI medication adherence.
Main Methods:
- The study employed the BCW framework for intervention development.
- A behavioral diagnosis identified barriers and facilitators to medication adherence, mapped to the COM-B model.
- Intervention functions and behavior change techniques (BCTs) were selected using APEASE criteria, with text messages co-developed by experts.
Main Results:
- The MedText-PCI intervention consists of 115 theory-informed text messages.
- The messages incorporate 15 distinct BCTs targeting treatment benefits, adherence consequences, action planning, and motivation.
- Expert review confirmed the clinical accuracy, clarity, and accessibility of the intervention content.
Conclusions:
- A theory-informed text message intervention (MedText-PCI) was successfully developed using the BCW framework for post-PCI medication adherence.
- The systematic development process ensures a reproducible basis for future research and clinical application.
- MedText-PCI shows promise for enhancing secondary prevention strategies in patients after PCI.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...